Nama's AI scorecard currently rates CME Group Buy (6.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is CME's P/E ratio?

CME Group trades at a trailing price-to-earnings ratio of 25.2.

When does CME report earnings?

CME Group's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $3.03.

What is the CME price target?

The median analyst price target from 16 analysts is $328.50, with a range of $227.00 – $367.00.

Is CME Shariah compliant?

Nama's AAOIFI-style screen reads CME Group as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.

Does CME pay a dividend?

Yes — CME Group's dividend yield is 1.7%.

Nama Insights

CME Group (CME)

Financial Services · Financial Data Stock Exchanges · NASDAQ

S&P 500

CME Group (CME) is a Financial Services company in the Financial Data Stock Exchanges industry. It has a market capitalization of $109.49B, a trailing price-to-earnings ratio of 25.2 and a free-cash-flow yield of 3.8%. Over the most recent reported fiscal year, revenue grew 6.4% and free cash flow per share grew 16.5%. Nama's AI scorecard rates it Buy, 6.3 out of 10. On 12-month momentum it ranks in the lagging band of its market.

AI scorecard

Buy · 6.3/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Lagging · -0.4% over 12 months ex. last

Second-worst fifth of its market on the past year's move.

Shariah screen

Shariah Compliant

Passes our debt, cash and income screen; not a scholar's ruling.

Off its high

-7.1%

How far the last close sits under the highest price of the past five years.

Market cap	$109.49B
Trailing P/E	25.2
Price / book	4.1
Price / sales	15.7
FCF yield	3.8%
Dividend yield	1.7%
Gross margin	86.6%
Operating margin	65.7%
Net margin	63.3%
Revenue growth (YoY)	+6.4%
Revenue growth (3-yr annual)	+9.1%
EPS growth (YoY)	+9.3%
FCF/share growth (YoY)	+16.5%
Beta	0.3
Exchange	NASDAQ
Sector	Financial Services
Industry	Financial Data Stock Exchanges

CME earnings

Next report: Feb 3, 2027 (Q4 2026, EPS estimate $3.03). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Oct 21, 2026	$3.02	$2.99	+1.0%	$1.74B
Q2 2026	Jul 22, 2026	$2.99	$2.91	+2.8%	$1.71B
Q1 2026	Apr 22, 2026	$3.36	$3.37	-0.3%	$1.88B
Q4 2025	Feb 4, 2026	$2.77	$2.74	+1.1%	$1.65B

CME analyst price target

Median target $328.50 from 16 analysts, ranging $227.00 – $367.00.

Financial Data Stock Exchanges peers

Ticker	Company	Market cap	P/E
SPGI	S&P Global	$135.62B	25.0
ICE	Intercontinental Exchange	$96.27B	21.6
MCO	Moody's	$87.19B	30.1
NDAQ	Nasdaq	$59.88B	26.6
MSCI	MSCI	$46.60B	33.3
CBOE	Cboe Global Markets	$36.86B	25.3
COIN	Coinbase Global	$35.68B	—
TRU	TransUnion	$15.48B	17.2

Explore live CME data on Nama Insights →

Recent Congressional trades

CME Group trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Alan Armstrong	Senate	Buy	$1,001 - $15,000	Jul 21, 2026
Gilbert Cisneros	House	Sell	$1,001 - $15,000	Jul 2, 2026
Gilbert Cisneros	House	Buy	$1,001 - $15,000	Feb 13, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Jan 15, 2026
Julie Johnson	House	Sell	$1,001 - $15,000	Dec 11, 2025
Valerie Hoyle	House	Sell	$1,001 - $15,000	Oct 10, 2025
Valerie Hoyle	House	Buy	$1,001 - $15,000	Sep 12, 2025
Julie Johnson	House	Sell	$1,001 - $15,000	Sep 11, 2025
Julie Johnson	House	Buy	$1,001 - $15,000	Sep 11, 2025
Julie Johnson	House	Buy	$1,001 - $15,000	Aug 14, 2025
Jefferson Shreve	House	Sell	$15,001 - $50,000	Jun 22, 2025
Rob Bresnahan	House	Buy	$1,001 - $15,000	May 8, 2025

CME FAQ

Is CME a buy?: Nama's AI scorecard currently rates CME Group Buy (6.3 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is CME's P/E ratio?: CME Group trades at a trailing price-to-earnings ratio of 25.2.
When does CME report earnings?: CME Group's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $3.03.
What is the CME price target?: The median analyst price target from 16 analysts is $328.50, with a range of $227.00 – $367.00.
Is CME Shariah compliant?: Nama's AAOIFI-style screen reads CME Group as Shariah Compliant. Passes our debt, cash and income screen; not a scholar's ruling.
Does CME pay a dividend?: Yes — CME Group's dividend yield is 1.7%.